Objective Gastric cancer(GAC) is the fifth most prevalent tumor in the world and also is the third leading cause of cancer-related death.The invasion and metastasis of GAC is a multi-step process and
Objective Although apatinib,immune checkpoint inhibitors,and trifluridine/tipiracil have shown promising results in phase Ⅲ randomized controlled trials(RCTs),there is no head-to-head comparison among